精確搜索結(jié)果
- Products
- 內(nèi)容類型
- Analysis Platform
- 語言
1 - 11 共 11 條結(jié)果
應(yīng)用的篩選條件
推動液相色譜生物治療藥物的表征 — 業(yè)內(nèi)專家組織的網(wǎng)絡(luò)研討會
安捷倫在線全自動多中心切割 MHC 2D-LC/MS 方案和智能化工作流程，將兩套或多套彼此獨立的 LC 分析流程進行整合，幫助制藥企業(yè)搭建了高效且自動化的分析方法平臺，賦能多肽藥物如司美格魯肽等 GLP-1 藥物的雜質(zhì)研究、純度和有關(guān)物質(zhì)分析與質(zhì)量控制。此平臺也是剖析原研藥以及仿制藥與原研藥比對研...
A Comparative Study of the Intact Mass, Subunit Mass, and Released Glycans of Two Rituximab Biosimilars Using High-Resolution LC/MS
The development and manufacturing of biosimilars require comparability studies with innovator biotherapeutic products.
LC/MS based characterization workflow of the GLP-1 therapeutic peptide liraglutide and its impurities using the 1290 Infinity II LC and 6545XT AdvanceBio LC/Q-TOF.
In the current study, We present a solid method for peptide quantification using capillary LC-MS/MS, emphasizing three key analytical parameters: (1) limit of detection (LOD) and limit of quantification (LOQ), (2) linear range for multiple peptides,...
In this application note, we explore some of the key parameters when comparing different column chemistries using ion-pair reversed-phase (IP-RP) separation of Semaglutide.
This application note presents an HPLC method development for the purity testing of semaglutide.
| 韓語 (朝鮮) | 完整版（PDF） |
|---|
This application note utilizes the 1260 Infinity II Bio Prime LC and InfinityLab LC/MSD iQ for the confirmation of GLP-1 (Liraglutide) sample.
This workflow ordering guide will help you quickly choose and order the right columns, standards, reagents, and supplies for the analysis of ADCs.
This application note demonstrates the resolution and robustness made possible with an Agilent TED in combination with an Agilent 1290 Infinity II Bio LC at elevated temperatures.